Recent patents in CRISPR technology

2016 Nature Biotechnology  
US 9,234,213 Engineered CRISPR-Cas9 systems for genomic modification in mammalian cells. Design and testing of a polynucleotide encoding the Streptococcus pyogenes protein in which the nucleotide sequence has been optimized for expression in mammalian cells. Also, all-in-one systems for RNA-guided genome engineering in mammalian cells, including human cells.
doi:10.1038/nbt.3579 fatcat:dbq3qnfuyneujp3xgabkwwlm5y